Outcomes by ALK Status (Immunohistochemistry or Fluorescence In Situ Hybridization) in ALEX. Li M. J Thorac Oncol 2022;17:e61-e62.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li M. Outcomes by ALK Status (Immunohistochemistry or Fluorescence In Situ Hybridization) in ALEX. J Thorac Oncol 2022;17:e61-e62.
PMID: 35623681